International Isotopes Inc. (INIS)
|Net Income (ttm)||-436,391|
|Trading Day||March 3|
|Day's Range||0.1200 - 0.1303|
|52-Week Range||0.043 - 0.2095|
IDAHO FALLS, Idaho, Jan. 26, 2021 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce the following developments. International Isotopes recently s...
International Isotopes Inc. Comments On The Unusual Trading Volume And Share Price Volatility In Its Common Stock
IDAHO FALLS, Idaho, Jan. 21, 2021 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company"), due to recent unusual trading volume, and share price volatility in its common stoc...
International Isotopes manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services. The company operates in five segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, and Radiological Services. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed tomography imaging, patient positioning, and calibration or operational testing... [Read more...]
Drug Manufacturers-Specialty & Generic
|IPO Date |
Aug 14, 1997
Stephen T. Laflin
|Stock Exchange |
|Ticker Symbol |
In 2019, INIS's revenue was $8.96 million, a decrease of -13.63% compared to the previous year's $10.37 million. Losses were -$1.52 million, 80.3% more than in 2018.
The average 12-month stock price forecast for INIS is 0.12, which is a change of 0.00% from the latest price.